A notable trend in the US Mycoplasma Testing Market is the substantial increase in testing volume, a reflection of heightened awareness and regulatory scrutiny. The market is projected to achieve a size of $1,529.59 million by 2035, with an impressive compound annual growth rate (CAGR) of 11.45%. This surge in volume speaks to the growing recognition among biopharmaceutical companies of the...